Yu Nie

ORCID: 0000-0002-8546-9873
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organ Transplantation Techniques and Outcomes
  • Liver Disease and Transplantation
  • Transplantation: Methods and Outcomes
  • Organ Donation and Transplantation
  • COVID-19 Impact on Reproduction
  • Renal and Vascular Pathologies
  • Cancer Mechanisms and Therapy
  • Gallbladder and Bile Duct Disorders
  • COVID-19 Clinical Research Studies
  • Neurological Complications and Syndromes
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • SARS-CoV-2 and COVID-19 Research
  • Pancreatic and Hepatic Oncology Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Urological Disorders and Treatments
  • Urinary and Genital Oncology Studies
  • Hepatitis C virus research
  • Acute Kidney Injury Research
  • Cancer Diagnosis and Treatment

Zhujiang Hospital
2022-2024

Southern Medical University
2022-2024

Eastern Hepatobiliary Surgery Hospital
2023

Second Military Medical University
2023

Abstract Objective This study aimed to evaluate the efficacy and safety of solid organ transplantation recipients inoculated with an inactivated COVID-19 vaccine. Methods We retrospectively analyzed antibody levels related adverse events non-transplantation subjects transplant recipients, both pre-transplantation (individuals awaiting transplantation) post-transplantation who have undergone transplantation), received vaccines from February 2021 July 2022. Results The included 38 vaccination...

10.1515/med-2024-0980 article EN cc-by Open Medicine 2024-01-01

Abstract Background The incidence of primary hepatocellular carcinoma (HCC) has remained high worldwide, and patients with advanced unresectable HCC are not in the minority. Previous studies have shown that oxaliplatin plus raltitrexed via Hepatic Arterial Infusion Chemotherapy(HAIC) can prolong Overall Survival(OS) Progression-Free Survival(PFS) HCC. However, almost all on this regimen for were non-randomized controlled trials had sample sizes, which may lead to a lack validity results...

10.21203/rs.3.rs-3246372/v1 preprint EN cc-by Research Square (Research Square) 2023-09-08

Umbilical incision implant cancer after LC is rare. Elective cholecystectomy was planned for a 49 years-old female patient with symptomatic gallstones. The underwent transumbilical single-port admission to our hospital. Gallbladder specimens were obtained directly through the umbilical puncture hole, and histopathology suggested chronic cholecystitis. Three months surgery, experienced painful induration in umbilicus. We initially considered scar hyperplasia complicated pain, used drugs treat...

10.3389/pore.2023.1611334 article EN cc-by Pathology & Oncology Research 2023-12-22

Acute kidney injury (AKI) is associated with adverse outcomes after liver transplantation(LT). The impact of intraoperative urine output(UO) on post-LT AKI remains unclear. 660 consecutive LT patients between 01/2015–12/2020 were analyzed. rates non-AKI, AKI-I, severe AKI(AKI-II and -III) 51.5%, 22.7% 25.8%. 38.1% 89.1% cases developed during operation or within 72h LT. As severity rose, the proportion SAKI remarkably increased from 19.3% to 65.7% creatinine maintained at significantly...

10.1097/01.tp.0000889108.92750.54 article EN Transplantation 2022-09-01

Background: The current binary definition of early allograft dysfunction (EAD) is not sufficiently accurate for discriminating clinical outcomes after liver transplantation (LT). It also criticized including heterogeneous diagnostic criteria with disparate severities outcomes. We investigated whether there are significant differences in among three EAD sub-criteria and explore the necessity dividing into different stages like acute kidney injury to grade severity graft dysfunction. Methods:...

10.1097/01.tp.0000889104.91032.c1 article EN Transplantation 2022-09-01
Coming Soon ...